Background {#j_jccm-2018-0023_s_001}
==========

Despite significant developments and advancements in antibiotic therapy life-threatening complication of infective diseases cause hundreds of thousands of deaths in the USA and millions more worldwide \[[@j_jccm-2018-0023_ref_001], [@j_jccm-2018-0023_ref_002]\].

*Sepsis* is the body\'s overwhelming and life-threatening response to infection which can lead to multiple organ systems failure. It is the body\'s immune system overresponse to infection following the release of inflammatory mediators such as cytokines into the blood circulation \[[@j_jccm-2018-0023_ref_003], [@j_jccm-2018-0023_ref_004]\]. Pro-coagulation factors in endothelial cells are activated causing local damages which will lead to a systemic inflammatory response syndrome (SIRS), septic shock and multiple organ dysfunction syndrome (MOSF) \[[@j_jccm-2018-0023_ref_005]\]. During such severe inflammatory stages, patients are often sedated and intubated, and the collection of relevant data requires well-developed communication skills \[[@j_jccm-2018-0023_ref_006]\]. This paper updates matters of abdominal sepsis etiology and treatment in the light of the latest guidelines outlined by the Intraabdominal Infection (IAI) Consensus (2017) \[[@j_jccm-2018-0023_ref_007]\].

Prognostic scores {#j_jccm-2018-0023_s_002}
=================

A diversity of prognostic scores are currently used to assess the course of peritonitis and intra-abdominal infections according to age, sex, the origin of sepsis, the degree of peritonitis, the time between any perforation to an operation and the type of exudates. Their objective is the early classification of patients presenting with peritonitis and intra‐abdominal sepsis through an objective scoring system, to aid in patient select for specific treatment modalities as well as to compare the results of different treatment regimens ([Table I)](#j_jccm-2018-0023_tab_001){ref-type="table"} Unfortunately, none of the current scoring systems satisfies all prerequisites \[[@j_jccm-2018-0023_ref_008], [@j_jccm-2018-0023_ref_009], [@j_jccm-2018-0023_ref_010], [@j_jccm-2018-0023_ref_011], [@j_jccm-2018-0023_ref_012], [@j_jccm-2018-0023_ref_013], [@j_jccm-2018-0023_ref_014]\].

###### 

Prognostic scores used to evaluate the prognostic of abdominal infection

  Prognostic scores                         Etiology
  ----------------------------------------- ------------------------------------
  Peritonitis Severity Score (PSS)          Left-sided colon perforation
  Boey Score                                
  Jabalpur Index                            
  Hacettepe Score                           Gastroduodenal ulcers perforations
  PULP Score                                
  Postoperative peritonitis                 Dutch leakage score
  P-POSSUM Score                            
  Mannheim Peritonitis Index (MPI)          
  Peritonitis Index Altona (PIA)            Peritonitis of all causes
  WSES complicated IAI score (WISS study)   

Peritonitis classification {#j_jccm-2018-0023_s_003}
==========================

Peritonitis can be classified by the anatomical integrity of the abdominal cavity. Primary peritonitis is associated with undamaged intra-abdominal cavity organs. It is also known as spontaneous bacterial peritonitis and is treated without surgical intervention. The source of infection is often hard to establish and is usually found occurring in infants and cirrhotic patients. Secondary peritonitis is an infection of the peritoneal cavity after hollow viscus perforation, anastomotic leak, ischemic necrosis, or other injuries of the gastrointestinal tract.

Secondary peritonitis, a common occurrence in critical surgical patients, is defined as an infection of the peritoneal cavity resulting from hollow viscus perforation, anastomotic leak, ischemic necrosis, or other injuries of the gastrointestinal tract. Tertiary peritonitis is defined as a serious recurrent or persistent intra-abdominal infection after the ostensibly successful control of secondary peritonitis \[[@j_jccm-2018-0023_ref_015], [@j_jccm-2018-0023_ref_016], [@j_jccm-2018-0023_ref_017]\].

Medical treatment of abdominal sepsis {#j_jccm-2018-0023_s_004}
=====================================

Irrespective of the cause, several measures are available and accepted as improving the survival rate, the most important being the early recognition of IAI. Efforts to achieve fluid balance should be initiated immediately to replace any intravascular insufficiency. Vasoactive agents may be necessary to augment and assist fluid restoration \[[@j_jccm-2018-0023_ref_018]\].

The WISS study showed that sepsis significantly influences mortality rate, this being only 1.2% in the absence of sepsis, increasing to 4.4% when sepsis is present and 71.8% when septic shock occurs \[[@j_jccm-2018-0023_ref_019]\].

Associated Microorganisms {#j_jccm-2018-0023_s_005}
=========================

Associated microorganisms differ according to the type of peritonitis and with the levels of perforation in secondary and tertiary peritonitis. When perforation is higher up in the alimentary tract, i.e. the stomach or the duodenum, bacterial contamination usually has less serious consequences whereas perforation of the colon and rectum leads to severe bacterial contamination which can be life-threatening and is the leading cause of sepsis and septic shock \[[@j_jccm-2018-0023_ref_020]\].

Primary bacterial peritonitis is associated with gram-negative *Enterobacteriaceae and*, *Streptococcus spp*., whereas secondary bacterial peritonitis is mainly linked to a polymicrobial infection of gram-negative *Enterobacteriaceae*, gram-positive *Enterococci and Staphylococci*, or anaerobes and candida. Tertiary peritonitis has a similar poly-microbial infection to secondary peritonitis, with common organisms isolated from patients being *Enterococcus*, *Candida*, and *Staphylococcus epidermidis* and are more likely to involve antibiotic-resistant strains \[[@j_jccm-2018-0023_ref_020]\].

Antibiotic therapy {#j_jccm-2018-0023_s_006}
==================

The Study for Monitoring Antimicrobial Resistance Trends (SMART) monitored the patterns of clinical gram-negative bacilli to antimicrobial agents. It reported the prevalence of extended-spectrum β-lactamase (ESBL)-producing *Enterobacteriaceae* in the clinical setting, to be of significant importance and acknowledged it to be increasing worldwide. In addition to the expected increased resistance to beta-lactams, fluoroquinolone resistance in ESBL-positive *Escherichia coli* causing intra-abdominal infections, ranges from 60 to 93 % \[[@j_jccm-2018-0023_ref_021],[@j_jccm-2018-0023_ref_022]\]. A comprehensive list of currently acceptable antibiotic therapy treatment related to peritonitis severity is given in [Table II](#j_jccm-2018-0023_tab_002){ref-type="table"} \[[@j_jccm-2018-0023_ref_023]\].

###### 

Currently acceptable antibiotic therapy treatment related to peritonitis severity

  Diagnosis                          Monotherapy                                  Combination therapy
  ---------------------------------- -------------------------------------------- -----------------------------------------------------
  Primary peritonitis                Ampicillin/Sulbactam                         2nd generation Cephalosporin
  Secondary peritonitis              Ampicillin/Sulbactam                         2nd generation Cephalosporin + Metronidazole
  low risk (localized peritonitis)   Carbapenem                                   3rd generation Cephalosporin + Metronidazole
  Secondary peritonitis              Ampicillin/Sulbactam                         2nd generation fluoroquinolone + Metronidazole
  low risk (diffuse peritonitis)     Piperacillin/Tazobactam                      
                                     Carbapenem (group 1/2)                       3rd or 4th generation Cephalosporin + Metronidazole
                                     Fluoroquinolone 4th generation Tigecycline   
  Secondary peritonitis              Piperacillin/Tazobactam                      4th generation Cephalosporin + Metronidazole
  high risk                          Carbapenem (group 1/2) Tigecycline           
  Tertiary peritonitis               According to resistance from microbiology    Antifungal therapy in high-risk patients

Surgical treatment of abdominal sepsis {#j_jccm-2018-0023_s_007}
======================================

IAI guidelines have published graded guidelines, A, B, C, D, for the medical and surgical treatment of abdominal sepsis, A, is a strong recommendation and D, one that is less robust in its recommendation\[[@j_jccm-2018-0023_ref_007]\].

Laparoscopic appendectomy is the primary treatment modalities recommended for perforated appendicitis. Antibiotic-therapy is used to supplement surgery or to delay a surgical procedure, though, on its own, it does not usually control an intraperitoneal infection \[[@j_jccm-2018-0023_ref_007]\]. According to Kong (2015), following retractable septic shock, the median overall length of hospital stay was five days, and the mortality rate was 1% \[[@j_jccm-2018-0023_ref_024]\].

In left colic perforated diverticular disease associated with a small abscess, treatment is commenced with antibiotics, with percutaneous drainage undertaken in cases of large abscess formation. The Hartmann procedure is used in cases of diffuse peritonitis and when progression to sepsis has occurred \[[@j_jccm-2018-0023_ref_025], [@j_jccm-2018-0023_ref_026]\], and in perforated colonic carcinoma, the Hartmann procedure is the first option of surgical treatment \[[@j_jccm-2018-0023_ref_027]\].

When local conditions allow, perforation subsequent to colonoscopy should be treated immediately by primary suture, if not the resection of the large bowel containing the perforation may be necessary \[[@j_jccm-2018-0023_ref_028], [@j_jccm-2018-0023_ref_029]\].

In gastroduodenal ulcer perforations, primary suturing, with or without an omentum patch, performed open or laparoscopically, is the treatment of choice \[[@j_jccm-2018-0023_ref_030],[@j_jccm-2018-0023_ref_031]\].

In small bowel perforation, primary suturing is the first option, but if it is associated with a large perforation or with a local ischemic condition, segmental resection is mandatory \[[@j_jccm-2018-0023_ref_032],[@j_jccm-2018-0023_ref_033]\].

Early cholecystectomy in acute cholecystitis is now recommended as being superior to the previously held opinion of delaying cholecystectomy, with a laparoscopic technique being the procedure of choice. The alternative, and considered to be the best option, especially when complications occurs, is a classical approach \[[@j_jccm-2018-0023_ref_034]\].

Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard for biliary decompression in patients with moderate to severe acute cholangitis, failing which, percutaneous biliary drainage (PTBD) is the second option\[[@j_jccm-2018-0023_ref_035],[@j_jccm-2018-0023_ref_036]\]. Ineffective control of the septic source is associated with significantly elevated mortality rates \[[@j_jccm-2018-0023_ref_037]\].

Pelvic inflammatory disease (PID) usually responds to antibiotic therapy, though surgical drainage is usually required in patients with a tubo-ovarian abscess \[[@j_jccm-2018-0023_ref_038],[@j_jccm-2018-0023_ref_039]\].

In cases of trauma accompanied by perforation, repair or anastomosis of the intestinal injuries should be considered in all cases. A colostomy is to be considered in colorectal injuries involving all layers when multiple injuries or comorbid conditions are present \[[@j_jccm-2018-0023_ref_040],[@j_jccm-2018-0023_ref_041]\].

Discussion {#j_jccm-2018-0023_s_008}
==========

Sepsis originates from infections caused by microorganisms such as bacteria, fungi, viruses or parasites. A clinical diagnosis of the source of infection, be it lung, cutaneous or kidney, or an abdominal abscess, or infection with or without neoplasia \[[@j_jccm-2018-0023_ref_042]\], is the initial step of identification of the causative agent \[[@j_jccm-2018-0023_ref_001]\]. Pathogenic agents have changed in recent years, due to the use of newer antibiotics \[[@j_jccm-2018-0023_ref_001]\]. The gram-negative bacteria, the *Pseudomonas aeruginosa* and gram-positive *Staphylococcus aureus* continue to be the most frequent pathogenic agent isolated from blood \[[@j_jccm-2018-0023_ref_001]\]. A recent increase in *Candida albicans* can be attributed to the use of antibiotic therapy and immunosuppressants \[[@j_jccm-2018-0023_ref_043]\]. Though extremely rare, sepsis caused by malaria-causing *Plasmodium falciparum* has been reported in the literature \[[@j_jccm-2018-0023_ref_044]\].

Stearns-Kurosawa (2011) outlined the pathogenesis of the severity of sepsis and septic shock and charted the criteria for the systemic inflammatory response syndrome (SIRS) \[[@j_jccm-2018-0023_ref_045]\].

SIRS may be induced by trauma, pulmonary emboli, or myocardial infarction \[[@j_jccm-2018-0023_ref_046]\].

Sepsis is considered to occur when SIRS is associated with an infection, and if sepsis progresses and there is resultant arterial hypotension, then septic shock ensues\[[@j_jccm-2018-0023_ref_047]\]. Sepsis by itself can lead to the development of secondary abdominal compartment syndrome, which severely compromises the patient's progress \[[@j_jccm-2018-0023_ref_048],[@j_jccm-2018-0023_ref_049]\].

The key relationship in the pathogenesis of sepsis is the gram-negative bacterial endotoxin lipopolysaccharide (LPS) being recognized as a marker for the detection of bacterial pathogen invasion and responsible for the development of an inflammatory response. Release of LPS into the circulation triggers a strong systemic pro-inflammatory response \[[@j_jccm-2018-0023_ref_043]\].

Cytokines release also represents a response against aggression. Tumor necrosis factor-a (TNF-a) and IL-1b are very well known in sepsis and septic shock involvement \[[@j_jccm-2018-0023_ref_050]\]. A systemic inflammatory response syndrome is triggered by high blood levels of cytokines one of them being IL-6 , initially described as B-cell-- stimulating factor. IL-6, encoded by a gene located in the chromosome 7p2 region, is a cytokine with an initial pro-inflammatory role in a systemic inflammatory response to infectious injuries \[[@j_jccm-2018-0023_ref_051]\]. The importance of IL6 as a prognostic factor has been studied with the development of IL6 inhibitors, such as monoclonal neutralizing antibodies against IL-6 and its gp80 receptor, as well as a soluble gp130 Fc fusion protein that inhibits IL-6/sIL-6R trans-signaling. As a result of multiple studies, tocilizumab, a monoclonal antibody that acts as an IL-6 receptor antagonist, has been approved for the treatment of rheumatoid arthritis \[[@j_jccm-2018-0023_ref_052]\].

Conclusions {#j_jccm-2018-0023_s_009}
===========

Abdominal cavity pathology is the second most common site of sepsis, with perforated appendicitis being the most frequent source of an abdominal infection. If it is not recognized, it can progress to septic shock with a 1% mortality rate. The intra-abdominal compartment syndrome is a complication of the progression of peritonitis. According to IAI guidelines, depending on the degree of the condition, antibiotic- therapy should be initiated as soon as possible.
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